EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Heron Neutron Medical Corp. (7799) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Heron Neutron Medical Corp. TWD 66.12, price TWD 543, upside -87.8%, quality 35 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · TW

HN Thin data Sep 24, 2026

Heron Neutron Medical Corp.

7799 · TW

Weakest SetupStrongly overvalued and low quality.

!Fair value 66.12 TWD · Strongly overvalued (−87.8%)
!Quality 35/100
!Weak Growth
!negative free cash flow
!Trails peers (1/6)
!Narrow moat 10/100
!Evidence only low, so the estimate is less certain
Watch Heron Neutron Medical Corp. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

961.00 TWD 194.00 TWD Fair Value 66.12 TWD Nov 2024 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

22‑month range 194.00 TWD – 961.00 TWD · fair‑value band 43.64 TWD – 82.65 TWD · the 543.00 TWD price screens above the 66.12 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Heron Neutron Medical in your weekly email

Every Wednesday you see whether Heron Neutron Medical is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments.

Show more

Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and is based in Zhubei, Taiwan.

Stock analysis

Heron Neutron Medical Corp. (7799) currently trades at 543.00 TWD, while our model-based Fair Value estimate is 66.12 TWD, 87.8% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 92/100, which puts the evidence level at low.

Scenario range: 43.64 TWD (bear) to 82.65 TWD (bull), the price of 543.00 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 35/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

Heron Neutron Medical Corp. reported revenue of 10.3M TWD in FY2025 versus 0 TWD in FY2022. Reported net income was −482M TWD in FY2025.

Key figures

Market cap 85.6B TWD (≈ $2.7B) · EPS (TTM) −3.03 TWD · Return on equity −7.7% · Return on assets (EBIT) −12.7% · Operating margin −28,244% · Revenue (TTM) 11.7M TWD · Revenue growth (YoY) −71.7% · Free cash flow −514M TWD.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).

What moves the price

The share trades about 27% below its 52-week high and 79% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −88%, 7799 screens richer than that median.

Fair Value models

Bear 43.64 TWD Fair Value 66.12 TWD Bull 82.65 TWD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) 36.30 TWD 48.65 TWD 72.60 TWD 51
All 1 models by family
Asset-Based
NCAV (Graham) 36.30 TWD 48.65 TWD 72.60 TWD 51

Open the full fair value analysis →

Notify me when 7799 reaches fair value

Put 7799 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 35/100

Of which business quality 40 · Market factors (momentum, volatility) 36

Profitability 1
Margins and returns on capital today
Quality Growth 75
Are margins and returns improving?
Cashflow 11
Earnings quality: real cash, not paper profit
Fin. Strength 92
Balance sheet, leverage, solvency risk
Investment 0
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 66
Price trend over the last 3–12 months (market factor)
52W Momentum 27
Distance to the 52-week high (market factor)
Net Issuance 61
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

7799 screens overvalued: fair value 88% below the price. Compare with Abbott Laboratories, →

Compare Heron Neutron Medical Corp. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 350 stocks

Beats the industry median on 1/5 measures
Overall it trails its industry peers.
Valuation
Quality Score 40 · Below median
Fair Value upside −87.8% · Bottom 25%
Profitability
Return on assets −5.8% · Below median
Growth and dividend
Revenue growth −71.7% · Bottom 25%

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/B 0.23× · Cheapest 25%

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $98.83 $74.79 −24%
Medtronic plc MDT $87.09 $65.61 −25%
Stryker Corporation SYK $278.77 $306.65 +10%
Boston Scientific Corporation BSX $43.65 $48.02 +10%
Edwards Lifesciences Corporation EW $85.19 $81.94 −4%
Siemens Healthineers AG SHL €37.86 €35.19 −7%
DexCom, Inc DXCM $86.68 $95.35 +10%
GE HealthCare Technologies Inc GEHC $66.63 $70.37 +6%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥153.86 ¥169.25 +10%
Koninklijke Philips N.V PHIA €21.87 €15.23 −30%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Heron Neutron Medical Corp. · Fair Value
66.12 TWD −88%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Heron Neutron Medical Corp. Fair Value". https://www.fairvalue-calculator.com/stock/7799

Frequently asked questions

Is Heron Neutron Medical Corp. (7799) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 66.12 TWD versus a price of 543.00 TWD, about −88% upside (overvalued).
What is the fair value of 7799?
Our model-based fair value for Heron Neutron Medical Corp. is 66.12 TWD (as of Sep 24, 2026), built from audited fundamentals. The current price: 543.00 TWD.
What is the quality score of 7799?
Heron Neutron Medical Corp. has a Quality Score of 35/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Heron Neutron Medical Corp. (7799)?
Our model-based price target is the fair value of 66.12 TWD (as of Sep 24, 2026) from 1 valuation models. Cautious scenario 43.64 TWD, optimistic scenario 82.65 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Heron Neutron Medical Corp. stock forecast for 2026?
Our models put fair value at 66.12 TWD, about −88% upside versus a price of 543.00 TWD (overvalued). Cautious scenario 43.64 TWD, optimistic scenario 82.65 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Heron Neutron Medical Corp. (7799)?
Heron Neutron Medical Corp. reported trailing-twelve-month revenue of about 11.7M TWD (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Heron Neutron Medical Corp. (7799)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Heron Neutron Medical Corp. it is 66.12 TWD per share (as of Sep 24, 2026), against a price of 543.00 TWD. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Heron Neutron Medical Corp. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 7799 trades above its calculated fair value: price 543.00 TWD, fair value 66.12 TWD, a gap of about −88% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 7799?
No. The price is what the market pays today (543.00 TWD); the fair value is what the company's own numbers justify (66.12 TWD). For Heron Neutron Medical Corp. the two are 476.88 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Heron Neutron Medical Corp. worth?
The market values Heron Neutron Medical Corp. at about 85.6B TWD (market capitalisation, as of Sep 24, 2026). Per share that is 543.00 TWD; our models calculate a fair value of 66.12 TWD per share.
What do the bullish and bearish scenarios say about 7799?
Our models span a range for Heron Neutron Medical Corp.: cautious scenario 43.64 TWD, base 66.12 TWD, optimistic 82.65 TWD per share (as of Sep 24, 2026, price 543.00 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Heron Neutron Medical Corp. (7799)?
Balance-sheet figures for Heron Neutron Medical Corp. (as of Sep 24, 2026): return on equity −7.7%. They feed the Quality Score of 35/100, which measures business quality independently of the share price.
How far is 7799 from its 52-week high?
Heron Neutron Medical Corp. trades at 543.00 TWD, about 27% below its 52-week high of 745.00 TWD and 79% above the low of 303.00 TWD (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of 66.12 TWD is for.
Which stocks are comparable to Heron Neutron Medical Corp.?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Heron Neutron Medical Corp. stock attractive at the current price?
The data as of Sep 24, 2026: price 543.00 TWD, calculated fair value 66.12 TWD (−88%), Quality Score 35/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 7799 calculated?
We run Heron Neutron Medical Corp. through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 66.12 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Heron Neutron Medical Corp. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Heron Neutron Medical Corp. (7799)?
The closing price on Oct 2, 2026 was 543.00 TWD. Our model-based fair value is 66.12 TWD, about −88% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Heron Neutron Medical Corp. right now?
The price sits above even our optimistic bull case (82.65 TWD). The favourable scenario is already priced in. Weak quality (35/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (43.64 TWD to 82.65 TWD) leaves room in how you read the outcome.

Key figures of Heron Neutron Medical Corp.

How large is the market capitalisation of Heron Neutron Medical Corp. (7799)?
The market capitalisation of Heron Neutron Medical Corp. is 85.6B TWD (≈ $2.7B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Heron Neutron Medical Corp. (7799)?
Earnings per share at Heron Neutron Medical Corp. are −3.03 TWD. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Heron Neutron Medical Corp. (7799)?
The return on equity (ROE) of Heron Neutron Medical Corp. is −7.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Heron Neutron Medical Corp. (7799)?
On an EBIT basis the return on assets of Heron Neutron Medical Corp. is −12.7% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Heron Neutron Medical Corp. (7799)?
The operating margin of Heron Neutron Medical Corp. is −28,244% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Heron Neutron Medical Corp. (7799)?
Revenue at Heron Neutron Medical Corp. is growing −71.7% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Heron Neutron Medical Corp. (7799) generate?
The free cash flow of Heron Neutron Medical Corp. is −514M TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch Heron Neutron Medical Corp. in the live analysis

One click puts Heron Neutron Medical Corp. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.